Median effective dose of intravenous nalmefene for preventing sufentanil-induced cough in children aged 1–6 years: a prospective randomized controlled trial - Top-Institutions - MDSpire

Determining the Median Effective Dose of Intravenous Nalmefene for the Prevention of Sufentanil-Induced Cough in Pediatric Patients Aged 1 to 6: A Prospective Randomized Controlled Study

  • By

  • Chao Wang

  • Fan Wang

  • Lijing Li

  • Xiaoxue Wang

  • Lanxin Qiao

  • Fang Wang

  • July 20, 2026

Share

Top Institutions in Pediatrics

Brief introduction explaining scope and methodology.

  • #1

    Beijing Children's Hospital
    Beijing Children's Hospital

    Beijing, Beijing

    Key Differentiators

    • Pediatrics

  • #2

    Shanghai Shuguang Hospital
    Shanghai Shuguang Hospital

    Shanghai, Shanghai

    Key Differentiators

    • Pediatrics

  • #3

    The Hospital for Sick Children
    The Hospital for Sick Children

    Toronto, Ontario

    Key Differentiators

    • Pediatrics

  • #4

    Second Affiliated Hospital of Shantou University Medical College
    Second Affiliated Hospital of Shantou University Medical College

    Shantou, Guangdong

    Key Differentiators

    • Pediatrics

  • #5

    First People’s Hospital of Tianshui
    First People’s Hospital of Tianshui

    Tianshui, Gansu

    Key Differentiators

    • Pediatrics

Original Source(s)

Median effective dose of intravenous nalmefene for preventing sufentanil-induced cough in children aged 1–6 years: a prospective randomized controlled trial

  • by Chao Wang, Fan Wang, Lijing Li, Xiaoxue Wang, Lanxin Qiao, Fang Wang

  • July 20, 2026

Related Content

The efficacy of tonsillectomy in the management of PFAPA syndrome: a systematic review and meta-analysis

Pediatric Dengue in the French Caribbean During an Epidemic

Successful outcomes of pediatric dacryocystorhinostomy with adjunctive 5-fluorouracil